Flex Biomedical Receives $866,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2800ac26-b90e-4cf6-b1aa-cea88431cbfe&Preview=1
Date
1/27/2011
Company Name
Flex Biomedical
Mailing Address
505 S. Rosa Road Madison, WI 53719
Company Description
Flex Biomedical’s lead product is a synthetic polymer, the Flex Polymer, designed to treat osteoarthritis, an incurable joint disease that affects millions around the world.
Website
http://www.flexbio.com
Transaction Type
Venture Equity
Transaction Amount
$866,000
Transaction Round
Undisclosed
Proceeds Purposes
Both new and existing investors participated in the round, which will be used to continue developing the Flex Polymer, a synthetic polymer viscosupplement for the treatment of osteoarthritis.
M&A Terms
Venture Investor
Undisclosed